And with a growing number of companies in the GLP-1 space, investors may be losing interest in the stock. Could Viking's ...

One answer may come from studying the dilution effect and an experiment on drug safety side effects information. On the way there, we need to start with the conventional wisdom in appellate practice.

Zimmer Biomet shares at $105 reveal value at 13 times adjusted earnings, as the company continues to grow despite a GLP-1 ...

Current Board’s Strategic, Management, and Capital Allocation Failures Have Driven an 80% Stock Decline Over Last 22 MonthsNew Leadership is ...

QphoX, Rigetti Computing (RGTI), and Qblox announced that their joint research demonstrating the ability to readout superconducting qubits ...

The drug supply is constantly evolving, and some experts suggest that a “fourth wave” of the opioid epidemic is underway, in ...

The University of Wisconsin Hospital and Clinics (UWHC) determined that alteplase should be used to lyse catheter clots, even though the drug is very costly at doses previously studied.

ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...

When things get hot, there’s no beating a chilled, caffeinated drink. But while there’s no question of what temperature we ...

We are here to defeat, delay, and dilute Trump’s extreme agenda at every ... and designating Mexican drug cartels as terrorist groups. The president also ended the Biden administration’s ...

The biggest companies, those that operate in more than one state, have as much as $6 billion in debt maturing next year, ...